Endocrine System
General Concepts
Homeostatic control
Endocrine cell (ductless) -> blood -> target cell (receptor)
Low conc. in plasma, high affinity, binds and stays (effects for a period of time)
Neuron -> synapse -> effector cell
Synapse is a tiny space, with high conc. of neurotransmitters, low affinity with quick control
Paracrine
Local Control
Autocrine
Self Control
Gap Junction
Contact Control
Endocrine glands
Ductless glands, secretions delivered by blood to target tissues
Regulate
Na and H2O balance
Ca balance
Energy Balance
Processes that cope with stress
Growth and development
Processes associated with Reproduction
Concentration and Function
Too much
Hyper secretion, hormone excess
Can also be turned off
Too litle
Hypo secretion, hormone insufficiency
Target cell resistance
Unresponsive to hormone
Eusecretion
Just nice
Regulated by
Rate of production
- mediated by + and - feedbacks
Rate of delivery: dependent on perfusion and mass action law
Rate of excretion/ degradation: half life in circulation
Mass action law: Hormones bound to carriers that are of lower affinity than receptors -> net transfer of hormones from carriers to receptors
Bound hormones to carriers have longer half life
Three types of hormones
Peptide and protein hormones
Pre-prohormone in RER , cleaved to prohormone in GA, Cleaved to hormone in secretory vesicle
Same synthesis and processing as secretory proteins, stored in secretory vesicle, soluble in plasma and usually not bound to carrier, short half life
Steroid hormones
Cholesterol -> Pregnenolone -> steroid hormones (different types)
Insoluble in plasma, transported via carrier proteins, synthesized and secreted on demand (cannot be stored), conversion in target tissues
Secreted by adrenal glands, gonads and placenta
Amino acid derivatives
- from tyrosine
Epinephrine
soluble in plasma, short half life, in medulla of adrenal gland
Throxine (Thyroid hormones)
Insoluble in plasma, transported via carrier, long half life, conversion in target tissues
Role of carrier proteins
Synthesized by liver
Extend half life in circulation
Sequesters hormone from target cell receptor
Total concentration = bound + free (active)
Mass action law
Receptor types and signaling
Cell surface
e.g. tyrosine kinase linked, inherent tyrosine kinase, Gprotein coupled
Secondary messenger signaling -> rapid metabolic changes
For steroid and thyroid hormones
Able to cross plasma membrane
Intracellular/nuclear receptor
Affect DNA transcription, change phenotype of cells, takes longer to change but have longer effects
Receptors determine Target cell response
Affinity
Conc. of hormone for half maximal response
High affinity -> low conc needed
Receptor no.
Cells with more receptors are more sensi to hormone
Competition
Binding by other agonist( or antagonist) reduces sensitivity
e.g. cortisol vs aldosterone
Saturation
Hormone conc. when all receptors are bound
remove hormone -> increase receptors to increase sensitivity due to less available hormone -> give hormone -> huge effect (rebound)
Types of reflex loops
Neural Control
- e.g. posterior pituitary
Increase [osmol] (stimulus) -> neuron -> ADH release -> kidney (target cell)
Hormonal control
- e.g. anterior pituitary
- H1 is tropic hormone for H2
Lower glucose (S) -> Hypothalamus -> GHRH (H1) -> AP -> GH (H2) -> LIVER (IGF-1)
Substrate Control
e.g. pancreatic islet, parathyroid
decrease [Ca] -> parathyroid -> PTH -> Bone (release Ca and PO4
Inactivation of response
Clearance: Removal of hormone
Receptor down regulation:
Sequestraion (remove receptor) or uncoupling
Removal of stimulus (-ve feedback)
Quantitative assays
Mix labeled hormone and hormone in plasma/urine with specific antibody
Mix of labeled and unlabeled hormone-AB complex
High sensitivity and specificity
Labels radioactive or fluorescent -> measure intensity
Can tell quantity, but cant tell if active
Bio assays: test for feedback loop activity
For hyposecretion of H-P-Adrenal axis
Use stimulation test to evaluate dysfunctional site leading to low cortisol
Give ACTH to promote cortisol secretion, assay cortisol levels after 60-90 minutes
If cortisol remains low -> adrenal dysfunctional (primary)
If cortisol increases -> either pituitary or hypothalamus is dysfunctional
For Hypersecretion of H-P-Adrenal Axis
Use suppresion test to evaluate site leading to high secretion of cortisol
give Dexamethasone to inhibit ACTH secretion, assay cortisol levels after 60-90 mins
If cortisol remains high, adrenal gland dysfunctional
If cortisol decreases, either pituitary or hypothalamus is dysfunction
Classification of pathology
Hypothalamus-Pituitary Axis
Regulates homeostasis
Hypothalamus secretes neuropeptides that control pituitary function in response to afferent signals from the brain, viscera and circulating levels of substrates and hormones
Pituitary secretes 8 hormones
Act directly on non-endocrine tissues (GH, PRL, ADH AND OT)
Act to modulate other endocrine glands (ACTH, TSH, FSH AND LH) and are called tropic peptides
- increase in size and no. of cells
Embryonic development
Posterior pituitary
When the diencephalon (brain) extends caudally
Joins with anterior pituitary, forming the median eminence (closest to brain), infundibulum (stalk) and pars nervosa
Consists of neural tissue
Anterior pituitary
Root of mouth loops up, forming Rathke's pouch
cuff formed around infundibulum -> pars tuberalis
Pars distalis (glandular tissue, forming anterior pituitary)
Unsealed loops of the pouch forms cysts and pars intermedia (between the two laeyers, consisting of glandular cells protruding into neural tissue)
Two portal systems
Hypothalamus to anterior pituitary
Posterior to anterior pituitary
Superior hypophyseal artery -> median eminence (receive releasing factors) -> long portal vessels -> anterior
Inferior hypophyseal artery -> posterior (receive ADH) -> short portal vessels -> anterior
Neurons in hypothalamus
Parvocellular neurons of paraventricular nucleus
Magnocellular neurons in supraoptic nucleus and PVN
Terminate in median eminence and secrete releasing factors (+ and -)
Secrete OT and ADH into capillaries of posterior lobe
Supraoptic -> ADH
PVN -> OT and abit of ADH
Hypothalamic neuropeptides
Called releasing factors (or inhibiting factors)
Secreted in episodic (perhaps circadian) and pulsatile manner
- Pulsatile to prevent down regulation from over secretions
Present at high conc. at target cell
Present in very low conc. in systemic blood
Releasing factors bind to plasma membrane receptors in pituitary target cells, release stored target hormone by exocytosis (short term) and increase transcription of target hormones
- will cause increase in size (hypertrophy) and number (hyperplasia) of target cells
Modulates own receptor activity (up/down regulation)
Feedback and chart
Growth Hormone
Secretion of GH in adults
Pulsatile and circadian rhythm
Increasing during early sleep
Decreased amplitude due to increase plasma glucose and aging
Activated by sleep, stress (depends) and low serum glucose, inhibited by high glucose
GH and Melanocortin axes
Empty stomach activates ghrelin (growth hormone releasing hormone), which activates the anterior pituitary to release GH, goes to liver, and releases IGF
- helps mobilize glucose and burnfat
Ghrelin also activates the hypothalamus Arcuate nucleus, which then inhibits Melanocortin receptors (MC4R) which originally decreases feeding
- thus increases feeding
Biological role
click to edit
Increases muscle (Decrease fuel storage)
Activates IGF-1 in the liver
Increase size and function of internal organs
- e.g. lung, heart, kidney
Lengthening of bones (together with GH directly)
In excess, GH is a diabetogenic, leading to hyperglycemia, lipolysis and hyperinsulinemia
GH, feeding and exercise
Diet
Amino acid
Insulin: yes
GH: yes
Effect: increase growth of muscle (seen with anaerobic training, not with aerobic
Glucose
Insulin: Yes
GH: No (Due to glucose intake)
Increase muscle glycogen (store)
Low glucose
Insulin: No
GH: yes (due to low glucose)
Effect: burn fuel from fat
GH excess
Before puberty
Gigantism
Overall increase in height in size as epiphyseal plate of bones are not closed yet
After puberty: Acromegaly
Coarsening of facial features, widening of fingers, toes, hands, feet
Prominent eyebrow ridge and jaws
All organs increase in size
Not good if it doesnt grow with axis of the body -> internal organ failure
- no lengthening of body due to mature epiphyseal plate
Give somatostatin or ablate pituitary tumor
IGF-1 will increase
Regulation of anterior pit
H-P-Thyroid axis
TRH-TSH-T4/T3
H-P-Adrenal
CRH-ACTH-Cortisol
H-P-Gonad
Kisspeptin-GnRH-LH/FSH-gonad
Posterior Pit
Receive unmyelinated axons from magnocellular neurons in PVN and supraoptic nucleus, which secretes OT and ADH into posterior pituitary
Oxytocin
Regulated by sucking and cry of infant
Increases myoepithelial contraction in breast and increases bonding (also contraction of uterin lining)
For both genders: sexual climax, stroking or hugging the baby for bonding
ADH
Regulated by osmotic and volume stimuli
rise in plasma osmolarity
Decrease of 15-20% in total blood vol, cardiac output or blood pressure
Act to raise blood vol by increasing reabsorption of water
Bind plasma membrane receptors, increase transcription of target genes, secondary messengers are Ca2+, DAG and cAMP
Pathology
Diabetes Insipidus
Central lesion due to trauma, inflammation or tumor
Nephrogenic lesion
X-linked (defective vasopressin receptor)
Autosomal: defective aquaporin-2 channels
Acquired: lithium treatment, hypokalemia and post-obstructive polyuria
Excess water intake
In stress
ADH and CRH secreted into median eminence enter anterior lobe by long portal vessels
ADH from posterior love enters anterior lobe by short portal vessels
Cosecretion of ADH with CRH potentiates ACTH secretion from anterior lobe
Thyroid Gland
Thyroid follicle and thyroid cells
Follicle (colloid) contains thyroglobulin, follicular cells produce and process the thyroglobulin
In normal thyroid follicle, the cells are cuboidal
In hyperthyroid follicle, cells are columnar due to extensive processing, with little follicle space as most of it has been used to produce thyroid hormones
In hypothyroid, cells are almost squamous due to almost no processing, while follicle is huge due to thyroglobulin still being retained inside
Thyroid hormone
Follicular Cell function
Number based on number of iodine
need 2 iodine on the inner ring to be active
relative activity: T3 > T4 > rT3 (inactive)
Synthesis
Na+-K+ ATPase transports Na+ out in exchange for 1 K+ in
Na+ iodide cotransporter moves in one iodide with 1 Na+
Iodide then converted to iodine
Thyroglobulin produced by RER of follicle cells and secreted into the lumen of the follicles for storage as colloid
Luminal membrane bound peroxidase conjugates adjacent pairs of tyrosines and adds iodine to the tyrosine residues
Resultant iodinated thyroglobulin in the preprohormone (2-3 months of supply)
In the absence of iodide, TH is not made
2 active hormones: Thyroxine (T4) and triiodothyronine (T3)
In response to TSH, iodinated thyroglobulin is endocytosed and cleaved to generate TH, which leaves the gland by a transporter (MCT) to enter the blood
Normal thyroid to serum ratio is 25:1, but in hyperthyroid, excess TSH can increase Na+-I symporters, increasing the activity and raising the ratio to at least 250:1
Each consist of two iodinated phenoli rings
Conversion of prohormone T4 to T3 occurs in the thyroid gland and in target tissues
Both are lipophilic with low solubility in plasma, bound to low affinity carrier proteins
less than 0.2% is free in the serum, and only free TH enters target cell
Despite lipid solubility, it was demonstrated that humans have two cell membrane bound transporters: MCT8 and OATP
MCT in particular is critical for uptake of TH from circulation across BBB and indirectly across CSF barrier into CNS neurons
Loss of MCT8 activity in humans results inprofound mental and motor retardation (Allan-Herndon-Dudley syndrome)
T4:T3 in plasma is 20:1
central regulation
Hypothalamus: parvocellular cells of PVN secrete TRH, which determines set point for axis
Goes to pituitary, secrete TSH, used to assay activity of thyroid gland
Thermal signals, caloric signals, leptin from fat regulates
Cold and feeding increase TRH production
Conversion in Target Tissues
BMR response to single equimolar dose of T3 will be higher than T4
T4 has longer half life, but also lower biological activity
Prohormone, T4, is converted to T3 in the thyroid gland and in target tissues, T3 therefore provides feedback
deiodinases regulate conversion
D1
Peripheral tissues, on plasma membrane, converts T4 to T3 + rT3
Determine T3 pool in hyperthyroidism, inhibited by propylthiouracil
D3
some peripheral tissues, fetus and placental unit
On plasma membrane
T4 converted to rT3
For clearance to clear body of T3 and T4
D2
In CNS, skeletal muscles, fat, heart, bone and thyroid gland
Activity increased by TH depletion and by increase sympathetic NS stimulation
determines 50% or more of T3 levels in eu and hypothyroid states, active in development and thermiogenesis
- skeletal muscle and brown fat
Perinuclear ER
Bound thyroid hormone receptor turns on transcription
Activate Na-K-ATPase, beta adrenergic receptors (increase HR), Glut 4 (increase glucose entrance into muscle) and others
TR saturation maximal in cells expressing D2
TR saturation minimal in cells expressing D3
Alters metabolism and thermogenesis
Accelerates Basal metabolic rate
Burns ATP, muscle and fat
Increase GLUT 4 in skeletal muscle
Increase rate of lipolysis and lipogenesis (to replace stores)
Thermogenesis by mitochondrial uncoupling
Adrenergic receptor upregulates uncoupling proteins (UCP) which is driven by free fatty acids fromlipolysis
In brown fat of fetus (UCP1)
In skeletal muscle of adult (UCP3)
during fasting
Free T4, Free T3 and TSH should decrease (with T3 decreasing to a greater extend)
D1 down regulated during fasting (T4 will thus be primary active form, lowering BMR)
D2 doesnt change in CNS, heart, thyroid gland and skeletal muscle to preserve activity, mediates feedback regulation in pituitary
leptin levels modulate TRH and TSH in starvation
High leptin will increase levels of TRH and on (fed state)
Will also activate melanocortin receptors, which inhibits feeding
Specific Tissue Actions
CVS
Hyper: increase HR, contractility and cardiac output, vasodilation
Reflects upregulation of beta adrenergic receptors
CNS
Hypo: mental Fog, lethargic, fatigue
Hyper: anxious, hand tremors, anxiety, weakness
Reproductive system and growth
Hypo: infertility, decrease LH secretion, retarded growth
Skin
Hypo: dry and puffy skin, hair loss, cold intolerance
Hyper: sweaty skin, heat intolerance, dryness or bulging of eyes
Pathologies
Hypothyroidism
Goiters
One of the most acquired endocrine disorders
Can occur with dietary iodine deficiency
Can also happen in hyperthyroidism
Hashimoto's thyroiditis
autoimmune disease that triggers apoptosis in thyroid follicular cells
Gland overstimulated
Congenital hypothyroidism (Creinism)
Partially reversible growth retardation
Irreversible mental retardation
Hyperthyroidism
present with exophthalamus (bulging eyes)
Grave's disease
Autoimmune disease in which circulating antibodies mimic TSH activity
T3 and T4 levels are high, TSH low
Goiters form due to overstimulation
Thyroid storm
True Emergency: Tachycardia, sweating, high fever
Treat with beta blocker, propylthiouracil (PTU) to inhibit iodination of thyroglobulin and D1 activity
Glucocorticoids to stimulate D3 activity
Parathyroid gland and Calcium homeostasis
Calcium involved in
Synaptic transmission and secretion
Second messenger
Protein secretion
Motility
differentiation and gene expression
Two time scales
Rapid transfer of calcium between ECF and bone -> moment to moment regulation
Slow rate: ingestion into and excretion from body
PTH governs both rapid and slow responses
regulation of plasma Ca
Exist as three forms: 50% ionized, 40% reversibly bound to protein, 10% bound to anions such as phosphate and citrate
Ionized and anion bound is filterable by kidney
Only free ionized Ca2+ is biologically active
pH is one of the most impt influences on amount of ionized Ca2+ in the blood
negatively charged plasma proteins have anionic sites that bind H+ or Ca2+
As pH rises, H+ dissociate from these sites and Ca2+ ions take its place, lowering plasma Ca2+
Patient with acute alkalosis is more susceptable to tetany (intermittent muscular spasms)
Ca2+ homeostasis = mass balance
PTH and Vit D govern movement of Ca2+
positive balance (growing child), net Ca2+ absorption from GI tract exceeds urinary excretion, difference is deposited in the bone
Negative Ca2+ balance (lactating mother), Ca2+ absorption from GI tract is insufficient and difference comes from bones
Parathyroid Hormone (PTH)
regulates serum ionized Ca2+ conc. byacting on bone, kidney and intestine
Net effect is to raise serum Ca2+ and simultaneously decrease serum phosphate conc
humans have 4 parathyroid glands, of which the chief cells produce the PTH
- produced as preprohormone, cleaved and stored
regulated by plasma Ca2+ conc. in simple -ve feedback
- When Ca in ECF is normal range or higher, PTH secreted at low basal rate
When decrease <10, PTH secretion strongly stimulated through a sensor coupled via G protein to adenylyl cyclase -> increase cAMP levels
Actions of PTH
Primarily to kidney and bone, where it binds to cells expressing PTH receptor (PTHR)
Bone
Affects all three cell types: osteocytes, osteoclasts and osteoblasts
occurs in phases
- Rapid absorption of Ca2+ into blood from fluid within bone canaliculli
- Slower reabsorption of Ca2+ into blood due to osteoclast degradation of mineralized bone which releases Ca2+ and phosphate into the ECF and degrades organic matrix of bone
- Late inhibition of osteoblasts prevent bone formation
doesnt directly affect osteoclasts (no receptors), could be paracrine signals from osteoblasts and osteocytes
Kidney
Promote phosphate excretion into urine by decreasing phosphate reabsorption in proximal renal tubules
- prevent deposition of Calcium Phosphate, an insoluble precipitate, within tissues and blood
Stimulate Ca2+ reabsorption in the distal renal tubules
PTH also increases conversion of VitD to its active form, calcitriol which acts on GI tract to promote uptake of Ca2_
Pathologies
Hyperparathyroidism
Primary: tumors (adenoma) that secrete excess PTH, blood Ca2+ elevated, PTH is high, surgery needed
Secondary: because of hypocalcemia due to chronic renal failure or Vit D deficiency, blood Ca2+ low but PTH high
Hypoparathyroidism
Consequence of thyroid or parathyroid surgery
Low circulating levels of PTH, decreased bone resorption and decrease Ca2+ reabsorption
Plasma Ca2+ low and phosphate is high
Also contain parafollicular cells (C cells) that secretes calcitonin (antagonist of PTH) to decrease blood calcium
- found outside follicles, fill in space between them
Pancreas
(Insulin and Glucagon)
In mammals, metabolism classified as 1 of 2 states
Fed state (anabolic)
Fasted state (Catabolic)
Immediately following a meal
Energy of nutrient molecules is transferred to high energy compounds for either immediate use or storage
When available nutrients in blood decreases, stored reserves mobilized either to perform work or generate heat
Most impt aspect of metabolism is regulated use of carbs, proteins and fats to generate glucose
Plasma glucose closely regulated at 80-100 mg/dL
Hour to hour regulation of glucose depends on antagonistic activities of insulin and glucagon (pancreatic hormones)
Control of hormones by factors such as diet, nutritional status and stress
high insulin:glucagon -> fed state and activates anabolic pathways
- storage of glucose as glycogen and fatty acids as triglycerides
High Glucagon:insulin -> fasting or "fight or flight" state -> increased levels of blood glucose (from glycogenolysis) and glycerol from lipolysis of fat
- free fatty acids used to generate ketones in the liver
Insulin secreted by pancreatic islet B cells when blood glucose higher than 80mg/dL
Glucagon secreted when blood glucose levels lower than 80mg/dL
Levels of insulin depend on blood glucose levels while levels of glucagon remains relatively steady during 24 hr period
Insulin and glucagon from pancreas
B cells in islets (more towards the core, bulk of the cells) produce insulin, ACh primes B cells secretion of insulin, but does so in a paracrine manner
a cells secrete glucagon
D cells produce somatostatin, PP cells secrete pancreatic polypeptide, e cells secrete ghrelin
Insulin
produced in RER as preproinsulin, where leader seq removed in ER and disulfide bonds formed to make proinsulin
Transferred to GA, where it is packed in secretory vesicles, and is further cleaved to remove the connecting peptide (C peptide), giving A and B chains of insulin
Removal of C-peptide exposes COOH terminal of insulin's B chain, allowing interaction of insulin receptor
C peptide stored with insulin, released and is an active peptide hormone involved in activation of Ca2+ dependent signaling pathways in renal and nerve tissues
Glucose timulation of insulin secretion
- when blood glucose rise >80mg/dL, glucose enters B cells via GLUT 2
- As glc enters, phosphorylated by glucose kinase to form G6P
- G6P metabolized (glycolysis), small increase in cytosolic ATP conc.
- Rise inhibits ATP gated K channels, which governs membrane potential
- When K channel close, no more K+ efflux, cell membrane depolarizes, opening voltage gated Ca2+ channels and Ca2+ enters
- influx activates phospholipase C, leading to production of diacylglycerol (DAG) and inositol phosphate (IP3)
- IP3 triggers Ca2+ release from ER, lead to secretion of insulin
- secretion terminated by activation of voltage gated K+ channels
In humans, IV infusion of glucose results in a biphasic pattern of secretion
Initial burst (5-10mins) of stored insulin
- Requires expression of insulin receptors on B cells
Second prolonged (30mins) phase of newly synthesized insulin
- Requires cell to cell contact between B cells and paracrine signalling
modulators of secretion
Hyperglycemia, elevated plasma amino acids and long chain fatty acids, as well as signals from autonomic nervous system and the GIT
e.g. consumption instead of IV glucose results in higher secretion of insulin due to incretin effect in response to carbs within the intestinal lumen
short chain fatty acids inhibit insulin secretion, somatostatin and catecholamines
Sulfonylurea drugs close ATP gated K+ channels, increasing insulin secretion from B islet cells in a subclass of DMTII individuals
Mechanism
Promtoes uptake of glucose from blood into cells
Enters all cells by GLUT 1 OR GLUT 2
in skeletal muscles and adipocytes, act to enhance by moving GLUT 4 to cell surface, glucose in cells kept low by rapid phosphorylation to G6P
Inactivation due to aggregation and endocytosis of insulin receptors, destruction in endosomes, degraded in liver and kidney
Promotes glycogen synthesis, inhibit glycogen degradation (improve glucose storage)
Stimulate lipogenesis and suppres lipolysis in adipose tissue, skeletal muscle and liver, inhibit hormone sensitive lipase resulting in accumulation of triglycerides and increase uptake of fatty acids from blood into adipose tissue and stored as triglycerides
stimulates amino acid transport into liver, skeletal muscle and fats, increase protein synthesis and inhibit protein degradation
deficiency
reduce flucose uptake into fat and muscle, excess glucose in blood and added production of glucose by liver
catabolism of protein, fat and glycogen and insufficient storage
Secretion of glucagon elevated, increasing lipolysis and gluconeogenesis
First consequence is protein deficiency, then overload of catabolic pathways wtih free fatty acids and triglycerides, which the liver converts to ketone bodies
As circulating levels of kotene rise, pH drops
Glucose excreted in urine
Diabetes Mellitus
Type 1 (insulin dependent diabetes mellitus, IDDM)
inability of pancreatic B cells to produce insulin
Must be injected with insulin daily
Long term control depends on maintaining balance between 3 factors: diet, exercise and insulin
Non-insulin-dependent diabetes mellitus (NIDDM or type 2)
Relative failure of pancreatic cell and/or by insulin resistance in muscle, fat and liver
rough stages
- Skeletal muscle first develops insulin resistance, leading to reduced GLUT 4 activity
- increased secretion of insulin followin gglucose ingestion -> increased insulin levels with normal glucose
- progression to pre-diabetic state characterized by loss of first phase of glucose dependent insulin secretion by pancreatic B cells as well as prolonged hyperinsulinemia and hyperglycemia
- High circulating levels of insulin diverts liver metabolism away from glycogen synthesis to glucose and fatty acid synthesis in response to glucose ingestion -> elevated plasma fatty acids, hyperglycemia and hyperinsulinemia
Dietary restriction supplemented with sulfonylurea drugs to enhance response of pancreatic B cells to glucose, with glitazone to reduce peripheral insulin resistance
In obesity related NIDDM, impaired capacity to switch between fed and fasting, leading to ectopic accumulation of fat in muscle and liver, leading to down regulation of insulin receptor and impaired GLUT 4 translocation to cell surface
- aerobic exercise and weight loss recomended, correcting islet B cell abnormalities and increasing insulin stimulated glucose uptake in skeletal muscles
In Maturity Onset Diabetes in the Young (MODY), mutations of glucokinase gene is the cause
- pt mutations in glucokniase gene alter sensitivity of islet B cell, requiring higher glucose levels to trigger insulin release
Gestational DM, during pregnancy
Acute complications
Ketoacidosis (metabolic) -> reduce blood vol, renal failure, coma and death
Hyper glycemia lead to fluid loss and dehydration (glucose in urine, increased urine output, loss of electrolytes)-> hyperosmolar coma
Corrective measuresL administration of base, fluids and insulin
Chronic Complications
circulatory and nervous systems
Deterioration of
Blood flow to retina of eye, causing retinopathy and blindness
BLood flow to extremities, causing need for amputation
Glomerular filtration in kidneys -> renal failure
Diminished sensation in extremities, impaired bladder and bowel functions
C-peptide replacement along with insulin may prevent development or retard progression of chronic complications in Type I disease
Glucagon
synthesized initially as preprohormone and is cleaved, released from pancreatic islet a cells when glucose <80mg/dL
Circulates unbound in plasma
potent hyperglycemic agent, acts on liver to promote gluconeogenesis but not in muscle, promotes glycogenolysis and ketone synthesis
Interact with cell surface receptors (G protein coupled receptor) which activates cAMP and Ca2+ (due to adenylate cyclase and release of IP3 respectively)
regulation
rise in plasma glucose levels >80mg/dL, enters cell, metabolized and glycolysed to form ATP, close K-ATP channel, leading to depolarization of cell
depolarization open voltage gated Ca2+ and Na+ channel, inhibition of glucagon secretion
Also regulated by insulin, where its presence potentiates suppressive effects of high glc
depolarization of B cell and entry of Ca2+ leads to depolarization of adjacent d-cell (gap junction) and secretion of somatostatin, which acts to hyperpolarize neighbouring a cell, inhibiting glucagon secretion
in Type I and type II diabetes (insulin resistance), no regulation of glucagon, thus baseline elevated
Stress increases glucagon secretion, mediated by sympathetic system to alpha adrenergic receptors and a and B islet cells, inhibiting insulin secretion, and promoting glucagon secretion
Adrenal Glands
Adrenal gland produces 3 major classes of hormones, net effect to maintain electrolyte balance, BP, plasma glucose levels and to suppress immune system
Split into two parts
Cortex
Medulla
mineralcorticoid (Aldosterone) on the outer layer (zona glomerulosa)
Glucocorticoid (cortisol) in zona fasciculata)
Sex Hormone (DHEA) in zona reticularis
epinephrine and norepinephrine
Hormones
Mineralcorticoids (aldosterone)
Glucocorticoids (cortisol)
Sex hormones (DHEA)
Maintains electrolyte and fluid balance
Affected by 21 and 11-hydroxylase (deificiency will cause no production of aldosterone)
Mobilize fueal depots, increasing plasma glucose
deficiency in 17,11 and 21 hydroxylase will cause no cortisol in system
weak ANDROGEN
Deficiency is 17 hydroxylase will cause no DHEA in system
Mineralcorticoids
in absence of aldosterone, plasma K+ levels increase with dietary intake and can reach life threatening levels
receptor found in many epithelial cells, including those that line the distal tubule of kidney and colon
Signals
Elevated angiotensin II due to low blood volume
elevated plasma K+
decrease inm serum K inhibits ANGII -stimulated release of aldosterone to prevent severe hypokalemia
elevated Na+ inhibits aldosterone release and activation of renin-angiotensin II by kidney
act on the kidney to increase reabsorption of Na+ and water and increase excretion of K+ in urine
acutely, ACTH from anterior pituitary will stimulate aldosterone production from z. glomerulosa, but aldosterone does not regulate the H-P-Adrenal axis (ACTH asecondary activator of aldosterone
Aldosterone bind to mineralcorticoid receptor of principal cells in kidney, increasing transcription of Na+ and K+ transporters on apical surface and of Na+-K+ ATPase on basolateral surface, resulting in increase Na absorption and K secretion
In low pH, aldosterone act on intercalated cell of collecting ducts to increase secretion of H+
insoluble in plasma, loosely bound to serum albumin and to transcortin
Pathology
Excess secretion leads to retention of Na, expansion of ECF vol, decreased K (Hypokalemia) and alkalosis
Deficiency leads to Na wasting, contracting of ECF vol, increase blood K+(hyperkalemia) and acidosis
aldosterone elevated and renin low -> primary pathology
aldosterone elevated and renin elevated -> secondary
Glucocorticoids
regulated by HPA axis, most common being cortisol which exibits circadian rhythem
Highest around time of awakening, lowest around midnight, and is related to sleep-wake patterns rather than dark-light.
Regulates cortisol secretion during times of stress
Physical
Hypoglycemia
Trauma
Heavy exercise
Dehydration
Psychological
Acute anxiety
Chronic anxiety
feedback loop
hypothalamus releases Corticotropin Releasing Hormone, which stimulates pituitary to secrete a large transcript called ProOpioMelanoCortin, which is cleaved to yield ACTH and endorphin (acts within CNS as an endogenous opoid)
ACTH (adrenocorticotrophin) stimulates cells of zona fasiculata to take up cholesterol and synthesize and release cortisol
As plasma cortisol rises, -ve feeddback to inhibit further secretion of ACTH and CRH
Breakdown of PROMC also produces melanin stimulating hormone (MSH), causing darkening of skin
ADH potentiates secretion of ACTH in presence of CRH
Not soluble in plasma, most bound to corticosteroid binding globulin, some to albumin with even lesser being free (only free available for binding to receptors)
Physiologic effects
Catabolic hormones, promte mobilization of fuel stores (protein in skeletal muscle, fatty acids and glycerol from adipose tissue)
Amino acids and glycerol converted by liver to glycogen, which is released into blood as glucose
Liver convert free fatty acids to ketones
combined effect of cortisol on three target organs is REINFORCEMENT
metabolic effects
Basal: increase gluconeogenesis in liver and lipolysis of fat
Excess (or pharmalogical doses) increase gluconeogenesis in liver, anti-inflammatory, immuno-suppressive, degradation of muscle, bone and skin, lipolysis of peripheral fat but deposition of visceral fat
- inhibits GH, thyroid hormone, insulin and sex steroids on target tissues
- Still used against asthma and rejection of transplants or inflammation
Mobilization of fuel stores, increased visceral fat and insulin resistnace
During stress, adrenal medulla also receive stimulation by sympathetic nervous system, releasing epinephrine
- inhibits insulin secretion from pancreas and moblization of triglycerides (lipolysis) from fat, thus keeping blood glucose levels high
Net effect of cortisol and EPI increases blood glucose, wasting of bone and muscle, loss of peripheral fats and deposition of omentum fats (neuropeptide Y upregulated, promoting growth)
insufficient cortisol -> increased resistance to insulin and poor capacity to generate substrate for gluconeogenesis -> hypoglycemic
molecular mechanism of action
Diffuse across plasma membrane and bind to intracellular receptors (GR), which was maintain in an inactive state by a chaperone
- glucocorticoid displace chaperone and steroid-GR complex moves to the nucleus
In nucleus, GR bind to glucocorticoid binding element (GRE) to control transcription, response time 60-90 mins
Cortisol similar in structure to mineralcorticoid, can bind to the receptor (MR)
under normal circumstances, specificity to mineralcorticoid is maintained through
carrier CBG has higher binding affinity for cortisol, lowering free cortisol in blood
Tissue sensitive to mineralcorticoids express enzyme 11,B-hydroxysteroid dehydrogenase type 2(11BHSD-2) which converts cortisol to cortisone (inactive) and cant bind to MR
- type 2 found in peripheral tissues
- type 1 coverts inactive cortisone to active cortisol in target tissues, leading to lipolysis
adrenal Pathophysiology
Addisons disease
entire adrenal gland destroyed or dysfunctional
Absence/lack of mineralcorticoid and blucocortic steroids
low serum Na and elevated serum K, low BP and increased skin pigmentation (no feedback from cortisol, excess ACTH)
unless mineralcorticoid is administered, K levels increase markedly with daily diet intake, could lead to cardiac arrest
Primary hyperaldosteronism (or Conn syndrome)
Excess aldosterone due to tumor in zona glomerulosa or bilateral hyperplasia of zona glomerulosa
decrease in K+ (hypokalemia), which can lead to arrhythmias and muscle weakness
Water retension an dhypertension
Renin should be decreased
Cushing's syndrome/disease
excess cortisol may be ACTH dependent (disease) or ACTH independent(syndrome, primary)
Mobilize glucose, hyperglycemia not correctde by insulin secretion (insulin resistant diabetes)
redistribution of fat from periphery to omentum fats
tanned in areas that receive no sunlight (due to excess ACTH)
thinning of skin as cortisol degrades the skin
Congenital bilateral adrenal hyperplasia
growth of cortex due to insufficiency of cortisol and consequent loss of -ve feedback on pituitary
DHEA does not feedback
congenital deficiencies occur in 17,21 or 11 hydroxylase
Catecholamines (medulla)
Epinephrine is primary catecholamine of adrenal, secreted by chromaffin cells, directly controlled by sympathetic nervous system
enzyme responsible for converting norepinephrine to epinephrine is induced by cortisol
norepinephrine is primary catecholamine of sympathetic nervous system
synthesis and secretion
begins with tyrosine, taken up by chromaffin cells in medulla and converted to NorEpi or Epi, which are then stored in granules
Secretion is stimulated by activation of sympathetic fibers of autonomic nervous system
Activated by stress, including exercise, hypoglycemia and trauma
adrenergic receptors and mechanism of action
bind to adrenergic receptors (a and B) on surface of target cells
Coupled to G proteins, which either stimulate or inhibit intracellular signalling pathways
involve changes in cAMP and free Ca
Physiological effects
Same effect on organs as direct stimulation by sympathetic nerves, although effect is more longer lasting
Can affect tissues and cells that are not innervated
effects
Increase HR and contraction of heart muscle
Vasoconstriction, increasing resistance and arterial blood pressure
Dilation of bronchioles to assist pulmonary ventilation
increased metabolic rate, oxygen consumption and heat production
Stimulation of liplysis in adipose cells and lactate from muscle to provide additional sources of energy in fight or flight response
Inhibit insulin release from pancrease to main elevated blood glucose
Epi is secreted with cortisol under stressful conditions, and acts on pancreatic islets to inhibit insulin secretion, removing opposing effects of insulin and increase secretion of glucagon
Net effect of Epi, cortisol and glucagon on blood glucose exceeds additive effect of ea hormone alone, and is called synergy